Drug No Help for Survival in Advanced Gastric Ca MedPage Today This study found that adding the targeted agent everolimus (Afinitor) to best supportive care in patients with advanced gastric cancer failed to improve overall survival, when compared to patients receiving best supportive care alone. ... |
